1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane multiple interactions EXP 6480464 2 more ... CTD PMID:19414516 1,2-dichloroethane decreases expression ISO RGD:10677 6480464 ethylene dichloride results in decreased expression of GPC3 mRNA CTD PMID:28960355 17alpha-ethynylestradiol decreases expression ISO RGD:10677 6480464 Ethinyl Estradiol results in decreased expression of GPC3 mRNA CTD PMID:17942748 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of GPC3 mRNA CTD PMID:15576828 more ... 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of GPC3 mRNA CTD PMID:26496021 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:737615 6480464 2 more ... CTD PMID:31675489 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:10677 6480464 Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to GPC3 promoter] CTD PMID:19654925 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:10677 6480464 Tetrachlorodibenzodioxin affects the expression of GPC3 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of GPC3 mRNA CTD PMID:21215274 2,4,6-tribromophenol increases expression ISO RGD:737615 6480464 2 more ... CTD PMID:31675489 2-acetamidofluorene increases expression EXP 6480464 2-Acetylaminofluorene results in increased expression of GPC3 mRNA CTD PMID:17187413 3',5'-cyclic AMP multiple interactions EXP 6480464 2 more ... CTD PMID:19414516 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:23196670 3,3',5,5'-tetrabromobisphenol A decreases expression ISO RGD:737615 6480464 tetrabromobisphenol A results in decreased expression of GPC3 protein CTD PMID:31675489 4,4'-sulfonyldiphenol increases expression ISO RGD:10677 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of GPC3 mRNA CTD PMID:30951980 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of GPC3 mRNA CTD PMID:24780913 , PMID:25825206 acetamide increases expression EXP 6480464 acetamide results in increased expression of GPC3 mRNA CTD PMID:31881176 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of GPC3 mRNA CTD PMID:28959563 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of GPC3 mRNA CTD PMID:23630614 , PMID:25378103 aflatoxin B1 decreases methylation ISO RGD:737615 6480464 Aflatoxin B1 results in decreased methylation of GPC3 gene CTD PMID:27153756 aflatoxin B1 decreases expression ISO RGD:737615 6480464 Aflatoxin B1 results in decreased expression of GPC3 mRNA CTD PMID:27153756 all-trans-retinoic acid decreases expression ISO RGD:737615 6480464 Tretinoin results in decreased expression of GPC3 mRNA CTD PMID:23724009 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of GPC3 mRNA CTD PMID:30779732 antirheumatic drug increases expression ISO RGD:737615 6480464 Antirheumatic Agents results in increased expression of GPC3 mRNA CTD PMID:24449571 aristolochic acid A decreases expression ISO RGD:737615 6480464 aristolochic acid I results in decreased expression of GPC3 mRNA CTD PMID:33212167 arsenous acid decreases expression ISO RGD:737615 6480464 Arsenic Trioxide results in decreased expression of GPC3 protein CTD PMID:33634982 atrazine increases expression ISO RGD:737615 6480464 Atrazine results in increased expression of GPC3 mRNA CTD PMID:22378314 benzo[a]pyrene affects methylation ISO RGD:737615 6480464 Benzo(a)pyrene affects the methylation of GPC3 5' UTR CTD PMID:27901495 benzo[a]pyrene decreases methylation ISO RGD:737615 6480464 Benzo(a)pyrene results in decreased methylation of GPC3 exon CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:10677 6480464 Benzo(a)pyrene results in decreased expression of GPC3 mRNA CTD PMID:32417428 benzo[a]pyrene increases methylation ISO RGD:737615 6480464 Benzo(a)pyrene results in increased methylation of GPC3 promoter CTD PMID:27901495 benzo[e]pyrene increases methylation ISO RGD:737615 6480464 benzo(e)pyrene results in increased methylation of GPC3 intron CTD PMID:30157460 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of GPC3 mRNA CTD PMID:18164116 beta-naphthoflavone decreases expression ISO RGD:737615 6480464 beta-Naphthoflavone results in decreased expression of GPC3 mRNA CTD PMID:32858204 bis(2-ethylhexyl) phthalate increases expression ISO RGD:737615 6480464 Diethylhexyl Phthalate results in increased expression of GPC3 protein CTD PMID:31163220 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of GPC3 mRNA, [bisphenol A co-treated with Testosterone] results in decreased expression of GPC3 mRNA CTD PMID:26496021 bisphenol A increases methylation ISO RGD:737615 6480464 bisphenol A results in increased methylation of GPC3 gene CTD PMID:31601247 bisphenol A multiple interactions ISO RGD:737615 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of GPC3 gene CTD PMID:31601247 bisphenol A increases expression ISO RGD:10677 6480464 bisphenol A results in increased expression of GPC3 mRNA CTD PMID:30951980 , PMID:34585602 bisphenol A affects expression ISO RGD:737615 6480464 bisphenol A affects the expression of GPC3 mRNA CTD PMID:30903817 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of GPC3 mRNA CTD PMID:25181051 , PMID:30816183 bisphenol F increases expression ISO RGD:10677 6480464 bisphenol F results in increased expression of GPC3 mRNA CTD PMID:30951980 cadmium atom multiple interactions ISO RGD:737615 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of GPC3 mRNA CTD PMID:35301059 cadmium dichloride multiple interactions ISO RGD:737615 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of GPC3 mRNA CTD PMID:35301059 cadmium sulfate multiple interactions ISO RGD:10677 6480464 cadmium sulfate inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in increased expression of GPC3 mRNA] CTD PMID:28189605 caffeine affects expression EXP 6480464 Caffeine affects the expression of GPC3 mRNA CTD PMID:20864626 carbamazepine affects expression ISO RGD:737615 6480464 Carbamazepine affects the expression of GPC3 mRNA CTD PMID:25979313 carbon nanotube decreases expression ISO RGD:10677 6480464 Nanotubes more ... CTD PMID:25554681 chlorpyrifos increases expression EXP 6480464 Chlorpyrifos results in increased expression of GPC3 mRNA CTD PMID:20691718 cisplatin increases response to substance ISO RGD:737615 6480464 GPC3 mRNA results in increased susceptibility to Cisplatin CTD PMID:25199881 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of GPC3 mRNA CTD PMID:26577399 cyclosporin A decreases expression ISO RGD:737615 6480464 Cyclosporine results in decreased expression of GPC3 mRNA CTD PMID:25562108 , PMID:27989131 DDT increases expression EXP 6480464 DDT results in increased expression of GPC3 mRNA CTD PMID:30207508 decabromodiphenyl ether decreases expression ISO RGD:737615 6480464 decabromobiphenyl ether results in decreased expression of GPC3 protein CTD PMID:31675489 dexamethasone increases expression ISO RGD:737615 6480464 Dexamethasone results in increased expression of GPC3 mRNA CTD PMID:25047013 dexamethasone multiple interactions ISO RGD:10677 6480464 [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in increased expression of GPC3 mRNA, cadmium sulfate inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in increased expression of GPC3 mRNA] CTD PMID:28189605 diarsenic trioxide decreases expression ISO RGD:737615 6480464 Arsenic Trioxide results in decreased expression of GPC3 protein CTD PMID:33634982 diuron decreases expression EXP 6480464 Diuron results in decreased expression of GPC3 mRNA CTD PMID:21551480 , PMID:25152437 dorsomorphin multiple interactions ISO RGD:737615 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin increases response to substance ISO RGD:737615 6480464 GPC3 mRNA results in increased susceptibility to Doxorubicin CTD PMID:25199881 entinostat decreases expression ISO RGD:737615 6480464 entinostat results in decreased expression of GPC3 mRNA CTD PMID:26272509 entinostat increases expression ISO RGD:737615 6480464 entinostat results in increased expression of GPC3 mRNA CTD PMID:27188386 entinostat multiple interactions ISO RGD:737615 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GPC3 mRNA CTD PMID:27188386 fenvalerate increases expression EXP 6480464 fenvalerate results in increased expression of GPC3 mRNA CTD PMID:30307764 fulvestrant multiple interactions ISO RGD:737615 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of GPC3 gene CTD PMID:31601247 furan increases expression EXP 6480464 furan results in increased expression of GPC3 mRNA CTD PMID:27387713 gemcitabine increases expression ISO RGD:737615 6480464 Gemcitabine results in increased expression of GPC3 mRNA CTD PMID:17039268 glycerol 2-phosphate multiple interactions ISO RGD:10677 6480464 [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in increased expression of GPC3 mRNA, cadmium sulfate inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in increased expression of GPC3 mRNA] CTD PMID:28189605 glycidol increases expression EXP 6480464 glycidol results in increased expression of GPC3 mRNA CTD PMID:24395379 hydroquinone O-beta-D-glucopyranoside decreases expression ISO RGD:737615 6480464 Arbutin results in decreased expression of GPC3 mRNA CTD PMID:17103032 indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of GPC3 mRNA CTD PMID:21396975 L-ascorbic acid multiple interactions ISO RGD:10677 6480464 [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in increased expression of GPC3 mRNA, cadmium sulfate inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in increased expression of GPC3 mRNA] CTD PMID:28189605 methapyrilene increases methylation ISO RGD:737615 6480464 Methapyrilene results in increased methylation of GPC3 intron CTD PMID:30157460 methotrexate increases response to substance ISO RGD:737615 6480464 GPC3 mRNA results in increased susceptibility to Methotrexate CTD PMID:25199881 methylmercury chloride decreases expression ISO RGD:737615 6480464 methylmercuric chloride results in decreased expression of GPC3 mRNA CTD PMID:28001369 Muraglitazar increases expression EXP 6480464 muraglitazar results in increased expression of GPC3 mRNA CTD PMID:21515302 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of GPC3 mRNA, thymoquinone inhibits the reaction [Diethylnitrosamine results in increased expression of GPC3 protein] CTD PMID:18164116 , PMID:35437842 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of GPC3 protein CTD PMID:35437842 N-nitrosodiethylamine multiple interactions ISO RGD:10677 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of GPC3 mRNA CTD PMID:24535843 N-nitrosodiethylamine increases expression ISO RGD:10677 6480464 Diethylnitrosamine results in increased expression of GPC3 mRNA CTD PMID:24535843 nickel atom decreases expression ISO RGD:737615 6480464 Nickel results in decreased expression of GPC3 mRNA CTD PMID:24768652 , PMID:25583101 ozone multiple interactions ISO RGD:10677 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of GPC3 mRNA CTD PMID:34911549 paclitaxel increases response to substance ISO RGD:737615 6480464 GPC3 mRNA results in increased susceptibility to Paclitaxel CTD PMID:25199881 panobinostat decreases expression ISO RGD:737615 6480464 panobinostat results in decreased expression of GPC3 mRNA CTD PMID:26272509 panobinostat multiple interactions ISO RGD:737615 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GPC3 mRNA CTD PMID:27188386 paracetamol affects expression ISO RGD:10677 6480464 Acetaminophen affects the expression of GPC3 mRNA CTD PMID:17562736 perfluorooctanoic acid decreases expression ISO RGD:737615 6480464 perfluorooctanoic acid results in decreased expression of GPC3 protein CTD PMID:26879310 phenobarbital multiple interactions ISO RGD:10677 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of GPC3 mRNA CTD PMID:24535843 phenylmercury acetate decreases expression ISO RGD:737615 6480464 Phenylmercuric Acetate results in decreased expression of GPC3 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:737615 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GPC3 mRNA CTD PMID:27188386 PhIP decreases expression EXP 6480464 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in decreased expression of GPC3 mRNA CTD PMID:15215175 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of GPC3 mRNA CTD PMID:19162173 pirinixic acid increases expression ISO RGD:10677 6480464 pirinixic acid results in increased expression of GPC3 mRNA CTD PMID:23811191 raloxifene increases expression EXP 6480464 Raloxifene Hydrochloride results in increased expression of GPC3 mRNA CTD PMID:15576828 SB 431542 multiple interactions ISO RGD:737615 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 scopolamine decreases expression EXP 6480464 Scopolamine results in decreased expression of GPC3 mRNA CTD PMID:12818353 Tesaglitazar increases expression EXP 6480464 tesaglitazar results in increased expression of GPC3 mRNA CTD PMID:21515302 testosterone multiple interactions EXP 6480464 [bisphenol A co-treated with Testosterone] results in decreased expression of GPC3 mRNA CTD PMID:26496021 tetrachloromethane multiple interactions ISO RGD:10677 6480464 AFR2 protein affects the reaction [Carbon Tetrachloride results in increased expression of GPC3 mRNA] CTD PMID:17668883 tetrachloromethane increases expression ISO RGD:10677 6480464 Carbon Tetrachloride results in increased expression of GPC3 mRNA CTD PMID:17668883 , PMID:29987408 thymoquinone multiple interactions EXP 6480464 thymoquinone inhibits the reaction [Diethylnitrosamine results in increased expression of GPC3 protein] CTD PMID:35437842 titanium dioxide decreases expression ISO RGD:10677 6480464 titanium dioxide results in decreased expression of GPC3 mRNA CTD PMID:23557971 tolcapone affects binding EXP 6480464 tolcapone binds to GPC3 protein CTD PMID:19783845 topotecan increases response to substance ISO RGD:737615 6480464 GPC3 mRNA results in increased susceptibility to Topotecan CTD PMID:25199881 trichostatin A decreases expression ISO RGD:737615 6480464 trichostatin A results in decreased expression of GPC3 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:737615 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GPC3 mRNA CTD PMID:27188386 trimellitic anhydride decreases expression ISO RGD:10677 6480464 trimellitic anhydride results in decreased expression of GPC3 mRNA CTD PMID:19042947 valproic acid increases methylation ISO RGD:737615 6480464 Valproic Acid results in increased methylation of GPC3 gene CTD PMID:29154799 valproic acid increases expression ISO RGD:737615 6480464 Valproic Acid results in increased expression of GPC3 mRNA CTD PMID:23179753 , PMID:27188386 valproic acid multiple interactions ISO RGD:737615 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GPC3 mRNA CTD PMID:27188386 valproic acid decreases expression ISO RGD:737615 6480464 Valproic Acid results in decreased expression of GPC3 mRNA CTD PMID:23179753 more ... valproic acid increases expression ISO RGD:10677 6480464 Valproic Acid results in increased expression of GPC3 mRNA CTD PMID:24896083 valproic acid affects expression ISO RGD:737615 6480464 Valproic Acid affects the expression of GPC3 mRNA CTD PMID:25979313 vancomycin decreases expression ISO RGD:10677 6480464 Vancomycin results in decreased expression of GPC3 mRNA CTD PMID:18930951 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of GPC3 mRNA CTD PMID:19015723 vincristine increases response to substance ISO RGD:737615 6480464 GPC3 mRNA results in increased susceptibility to Vincristine CTD PMID:25199881 vorinostat multiple interactions ISO RGD:737615 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GPC3 mRNA CTD PMID:27188386 vorinostat decreases expression ISO RGD:737615 6480464 vorinostat results in decreased expression of GPC3 mRNA CTD PMID:26272509 zoledronic acid decreases expression ISO RGD:737615 6480464 zoledronic acid results in decreased expression of GPC3 mRNA CTD PMID:24714768